Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)
(Real Time Quote from BATS)
$1.46 USD
-0.01 (-0.68%)
Updated Aug 4, 2025 10:24 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Scinai Immunotherapeutics Ltd. Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SCNI 1.46 -0.01(-0.68%)
Will SCNI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SCNI based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SCNI
Scinai Immunotherapeutics' PC111 featured in peer-reviewed publication
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Scinai (SCNI) Highlights Progress with PC111 in Dermatological Treatments
Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy ...
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket